Syntro Corp.

Company Information

Company Name
Syntro Corp.
Address
10655 Sorrento Valley Rd
San Diego, CA, 92121
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
75
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$349,504.00
7
SBIR Phase II
$1,635,655.00
4

Award List

  1. BIOLOGICALLY PRODUCED MACRO-MOLECULES FOR AVIATION MATERIAL

    Amount: $500,000.00

    SYNTRO CORP HAS DEVELOPED THE MEANS OF CONSTRUCTING ARTIFICIAL GENES, AND FOR THE EXPRESSION OF THESE GENES AS MACRO-MOLECULES IN BACTERIA. THE CORPORATION PROPOSES TO PERFECT THIS TECHNOLOGY AND USE ...

    SBIR Phase II 1985 NavyDepartment of Defense
  2. ALTERNATIVE SOURCE FOR METAL CHELATION COMPOUNDS

    Amount: $485,655.00

    THERE IS A NEED FOR CHEMICALS WITH A HIGH METAL BINDING CAPACITY WHICH ALSO ALLOWS FOR RECOVERY OF THE METALS IN A CONCENTRATED FORM. THIS CHEMICAL SHOULD PERMIT REPEATED RECYCLING, FUNCTION AT LOW ME ...

    SBIR Phase II 1987 Department of Energy
  3. HUMAN CYTOMEGALOVIRUS (HCMV) IS A SIGNIFICANT HUMAN PATHOGEN.

    Amount: $49,875.00

    HUMAN CYTOMEGALOVIRUS (HCMV) IS A SIGNIFICANT HUMAN PATHOGEN. WHILE HCMV INFECTION DOES NOT PRODUCE DISEASE IN THE MAJORITY OF CASES, MAJOR PROBLEMS MAY DEVELOP FROM CONGENITAL INFECTIONS OR IN IMMUNO ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) IS ALMOST CERTAINLY THE CAUSAL AGENT OF THE EPIDEMIC HUMAN DISEASE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS).

    Amount: $50,000.00

    HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) IS ALMOST CERTAINLY THE CAUSAL AGENT OF THE EPIDEMIC HUMAN DISEASE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS). AIDS IS A MAJOR HEALTH PROBLEM IN THE U.S.; ...

    SBIR Phase I 1986 Department of Health and Human Services
  5. EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

    Amount: $500,000.00

    MALARIA IS ONE OF THE MOST IMPORTANT PARASITIC DISEASES OF MAN. IT IS CAUSED BY SPECIES OF THE PROTOZOAN PLASMODIUM WHICH HAVE A COMPLEX LIFE CYCLE OF SEVERAL DEVELOPMENTAL STAGES THAT OCCUR IN BOTH M ...

    SBIR Phase II 1988 ArmyDepartment of Defense
  6. VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

    Amount: $150,000.00

    THE IMMUNODOMINANT ANTIGEN OF INFECTIOUS BURSAL DISEASE VIRUS HAS BEEN SHOWN TO BE A 32 KD STRUCTURAL PROTEIN. MONOCLONAL ANTIBODY, DIRECTED AGAINST THE PROTEIN, PASSIVELY PROTECTS CHICKS. SYNTRO HAS ...

    SBIR Phase II 1988 Department of Agriculture
  7. IMPROVED REAGENTS FOR SYPHILIS DIAGNOSIS

    Amount: $50,000.00

    A PROJECT TO DEVELOP A STATE-OF-THE-ART SERODIAGNOSTIC ASSAY FOR SYPHILIS WITH RECOMBINANT TREPONEMA PALLIDUM ANTIGENS IS PROPOSED. THE DEVELOPMENT OF RECOMBINANT DNA-DERIVED REAGENTS WOULD BE OF GREA ...

    SBIR Phase I 1987 Department of Health and Human Services
  8. BIOLOGICALLY PRODUCED MACRO-MOLECULES FOR AVIATION MATERIAL

    Amount: $49,980.00

    N/A

    SBIR Phase I 1983 NavyDepartment of Defense
  9. VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

    Amount: $49,992.00

    N/A

    SBIR Phase I 1987 Department of Agriculture
  10. EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

    Amount: $49,950.00

    N/A

    SBIR Phase I 1986 ArmyDepartment of Defense

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government